Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH
Alcohol Use Disorder, Alcoholic Hepatitis
About this trial
This is an interventional treatment trial for Alcohol Use Disorder focused on measuring Alcohol treatment, Liver transplant, Motivational intervention, Cognitive-behavioral therapy
Eligibility Criteria
Inclusion Criteria:
- English speaking
Exclusion Criteria:
- too medically/psychiatrically ill to participate
- not able to provide informed consent due to cognitive impairment
Sites / Locations
- Johns Hopkins University School of MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Integrated AUD Treatment (IAT)
Treatment As Usual
IAT will include computer-delivered CBI in the hospital, nurse-delivered clinical monitoring and treatment adherence counseling, and at-home participation in web-based, 7-session computerized cognitive-behavioral therapy (CBT4CBT), supplemented by tailored text messages. Alcohol pharmacotherapy will be added to behavioral treatments as needed.
All LT patients receive physician instructions to not drink alcohol. Consistent with current discharge procedures, AH patients are encouraged to engage in alcohol treatment services. Patients receive regular blood draws for monitoring of liver function, and regular phone calls for post-operative monitoring.